Key Takeaways
- • Align Capital Partners acquires Heritage Imaging, a Boise-based mobile diagnostic imaging provider operating across 14 states, establishing a new platform for rural healthcare service expansion through outsourced imaging.
- • Heritage operates a multi-modality platform delivering PET/CT, MRI, nuclear medicine, ultrasound, and echocardiography services to critical access hospitals and underserved rural facilities that cannot justify dedicated in-house imaging capacity.
- • Heritage has completed three add-on acquisitions since 2024 and plans continued M&A under ACP partnership, targeting adjacent outsourced imaging models and expansion into new modalities as part of a disciplined consolidation strategy.
- • The U.S. diagnostic imaging centers industry reached $26.3 billion in market size in 2026, with mobile and outsourced imaging gaining share as rural and community hospitals seek cost-effective alternatives to capital-intensive permanent installations.
- • ACP targets companies with $3–$15 million EBITDA and enterprise values up to $150 million, with investment range of $20–$60 million, positioning Heritage as a scaled platform for continued roll-up activity in the healthcare services sector.
Summary
Align Capital Partners has acquired Heritage Imaging, a mobile diagnostic imaging provider based in Boise, Idaho, in a transaction that establishes Heritage as a new platform for ACP's healthcare services expansion strategy. Heritage operates across 14 states, delivering diagnostic imaging services to hospitals, community clinics, and critical access hospitals in underserved and rural markets where patient volume cannot justify permanent, full-time imaging equipment installations. The company was founded in 1989 as MRI Mobile and has evolved into a multi-modality provider offering PET/CT, MRI, nuclear medicine, ultrasound, echocardiography, and additional services, with fully staffed mobile units arriving ready for deployment.
The acquisition addresses a structural inefficiency in rural healthcare delivery. Critical access hospitals—small facilities receiving enhanced Medicare reimbursement to maintain essential services in rural areas—face a paradox: their patient populations carry significant diagnostic needs but lack volume to justify dedicated imaging equipment. Heritage's outsourced mobile model eliminates the capital barrier while reducing patient travel time and enabling earlier diagnosis in regions where the nearest full-service imaging center may be located hours away. This value proposition has resonated with hospital administrators managing both clinical quality and cost constraints.
Heritage's operational trajectory demonstrates strong momentum preceding the ACP acquisition. The company has completed three add-on acquisitions since 2024, systematically building geographic coverage and service-line depth. Under ACP's ownership, Heritage will pursue additional acquisitions with an initial focus on adjacent outsourced imaging models and expansion into new diagnostic modalities. Dr. Steve Coppess, Heritage's CEO, emphasized that ACP's operational resources and M&A track record align with the company's expansion objectives, while Rob Langley, a managing partner at ACP, cited Heritage's reputation as a trusted rural imaging partner and its history of customer retention as key investment drivers.
The market backdrop supports continued consolidation in mobile and outsourced imaging. According to IBISWorld data cited in the announcement, the U.S. diagnostic imaging centers industry reached $26.3 billion in market size in 2026, growing at a 1.7% compound annual growth rate between 2021 and 2026. Within this market, mobile and outsourced imaging represents a growing segment as smaller healthcare systems seek advanced diagnostic capabilities without proportional capital investment. ACP, which closed its third fund in November 2022 with $620 million in capital commitments, invests between $20 million and $60 million in North American companies with EBITDA ranging from $3 million to $15 million and enterprise values up to $150 million, positioning Heritage as a scaled acquisition vehicle within its healthcare and specialty services focus areas.
The acquisition addresses a structural inefficiency in rural healthcare delivery. Critical access hospitals—small facilities receiving enhanced Medicare reimbursement to maintain essential services in rural areas—face a paradox: their patient populations carry significant diagnostic needs but lack volume to justify dedicated imaging equipment. Heritage's outsourced mobile model eliminates the capital barrier while reducing patient travel time and enabling earlier diagnosis in regions where the nearest full-service imaging center may be located hours away. This value proposition has resonated with hospital administrators managing both clinical quality and cost constraints.
Heritage's operational trajectory demonstrates strong momentum preceding the ACP acquisition. The company has completed three add-on acquisitions since 2024, systematically building geographic coverage and service-line depth. Under ACP's ownership, Heritage will pursue additional acquisitions with an initial focus on adjacent outsourced imaging models and expansion into new diagnostic modalities. Dr. Steve Coppess, Heritage's CEO, emphasized that ACP's operational resources and M&A track record align with the company's expansion objectives, while Rob Langley, a managing partner at ACP, cited Heritage's reputation as a trusted rural imaging partner and its history of customer retention as key investment drivers.
The market backdrop supports continued consolidation in mobile and outsourced imaging. According to IBISWorld data cited in the announcement, the U.S. diagnostic imaging centers industry reached $26.3 billion in market size in 2026, growing at a 1.7% compound annual growth rate between 2021 and 2026. Within this market, mobile and outsourced imaging represents a growing segment as smaller healthcare systems seek advanced diagnostic capabilities without proportional capital investment. ACP, which closed its third fund in November 2022 with $620 million in capital commitments, invests between $20 million and $60 million in North American companies with EBITDA ranging from $3 million to $15 million and enterprise values up to $150 million, positioning Heritage as a scaled acquisition vehicle within its healthcare and specialty services focus areas.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.